Micron Soars on Record $41.5 Billion Quarter as AI Memory Boom Continues
Micron delivered its strongest quarter ever with revenue more than quadrupling to $41.46B. Record earnings and strong Q4 guidance send shares higher after hours.
NOTRELOAD AI
Major Housing Bill Clears Congress with Strong Support as Homebuilder Stocks Rally
Congress approves sweeping housing legislation to accelerate construction and limit Wall Street investors. Trump delays signing, but markets cheer the supply-boosting reforms.
Nancy Pelosi Discloses Up to $6 Million in Bullish Intel and Uber Call Options
Her first major trades since early 2026.
Raymond James Highlights Viking’s New Amylin-Based Weight Loss Drug VK3019 Entering Clinic
Viking Therapeutics advances its obesity portfolio with the start of a Phase 1 trial for VK3019, a novel dual amylin and calcitonin receptor agonist. Analyst sees major potential.
Cantor Fitzgerald Initiates Overweight Coverage on Silence Therapeutics, Calls Stock “Materially Undervalued”
The firm initiated Overweight coverage citing strong divesiran Phase 2 potential and 160%+ upside.
CEO Moshe Mizrahy’s Group Offers to Take InMode Private at $16.20 Per Share
Board forms special committee to evaluate the offer.